Lack of short-term efficacy of rituximab upon symptoms of ankylosing spondylitis treated for an associated vasculitis.
Wendling
Daniel
D
Augé
Benoit
B
Streit
Gérald
G
Toussirot
Eric
E
Mathieu
Sandra
S
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069283:Rituximab; D013167:Spondylitis, Ankylosing / Q000150:complications / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome; D014657:Vasculitis / Q000150:complications / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab